Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Clinical Genitourinary Cancer|October 19, 2017
Abiraterone Followed by Enzalutamide Versus Enzalutamide Followed by Abiraterone in Chemotherapy-naive Patients With Metastatic Castration-resistant Prostate CancerNobuaki Matsubara, Yoko Yamada, Ken-Ichi Tabata, et al.
Oncogene|May 11, 2021
Functional inhibition of cancer stemness-related protein DPP4 rescues tyrosine kinase inhibitor resistance in renal cell carcinomaShuhei Kamada, Takeshi Namekawa, Kazuhiro Ikeda, et al.
The American Journal of Case Reports|March 7, 2025
Two Cases of Revisional Urinary Diversion from Ureterocutaneostomy to Ileal Conduit: A Staged Urinary Diversion Strategy for Patients with Bladder Cancer in the Targeted and Immunotherapy EraYuki Tanaka, Hideki Takeshita, Kazuki Yokota, et al.
Cancer Science|November 19, 2025
Prognostic Impact of DPP4 Inhibitors on Systemic Drug Therapy for Advanced Kidney Cancer PatientsShuhei Kamada, Sachi Kitayama, Ryosuke Yamase, et al.
BJUI Compass|April 27, 2022
A novel prognostic model for Japanese patients with newly diagnosed bone-metastatic hormone-naïve prostate cancerYasuhide Miyoshi, Masato Yasui, Shuko Yoneyama, et al.
BMC Cancer|May 1, 2026
Enfortumab vedotin in ECOG-PS 2 advanced urothelial carcinoma patients: a real-world study from the ARON-2EV projectAlessandro Rizzo, Francesco Ciccimarra, Stenio de Casio Zequi, et al.
European Urology Open Science|November 24, 2025
Efficacy of Enfortumab Vedotin After Platinum Chemotherapy and Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Real-World Analysis of the ARON-2EV CohortOndrej Fiala, Francesco Grillone, Kazutoshi Fujita, et al.
Targeted Oncology|October 1, 2024
Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2EV StudyOndřej Fiala, Francesco Massari, Umberto Basso, et al.
Pageof 5